RDHL
REDHILL BIOPHARMA LTD-SP ADR
1 day chart
About RDHL
Redhill Biopharma Ltd is an Israel-based specialty biopharmaceutical company, principally focused on gastrointestinal (GI) and infectious diseases. The Company is focused on the commercialization in the United States (U.S.) of the GI-related products, Movantik (naloxegol),Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). A part form Company's pipeline consists of six therapeutic candidates RHB-204 dedicated to Nontuberculous mycobacterial (NTM) treatment, RHB-104 dedicated to Crohn's disease, RHB-102 antiemetic drug ondansetron, in development for multiple gastrointestinal indications, RHB-106 an oral capsule formulation for bowel preparation, Opaganib an inhibitor, administered orally, with anticancer, anti-inflammatory and anti-viral activities and RHB-107 inhibitor of serine proteases targeting multiple indications, including COVID-19, cancer, inflammatory lung diseases and gastrointestinal diseases.
Buy US stocks in Australia with $0 brokerage and trade RDHL today!
$26.76M
-
0.00%
1.11M
$0.55
$0.49
$0.53
$6.50
$0.47
Related Stocks
This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.